Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,202 JPY | +4.11% | +3.09% | +25.83% |
2023 | Kakuyasu Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings | RE |
Sales 2024 * | 131B 833M 66.53B | Sales 2025 * | 142B 900M 71.86B | Capitalization | 20.85B 132M 10.58B |
---|---|---|---|---|---|
Net income 2024 * | 1.87B 11.89M 950M | Net income 2025 * | 2.01B 12.8M 1.02B | EV / Sales 2024 * | 0.21 x |
Net Debt 2024 * | 6.08B 38.64M 3.09B | Net Debt 2025 * | 4.38B 27.81M 2.22B | EV / Sales 2025 * | 0.18 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
9.89
x | Employees | 1,592 |
Yield 2024 * |
2.36% | Yield 2025 * |
2.48% | Free-Float | 21.88% |
1 day | +4.11% | ||
1 week | +2.04% | ||
Current month | +8.26% | ||
1 month | +6.17% | ||
3 months | +22.88% | ||
6 months | +3.48% | ||
Current year | +25.83% |
Managers | Title | Age | Since |
---|---|---|---|
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 30/11/09 |
Hiroyuki Maegaki
DFI | Director of Finance/CFO | - | 30/09/02 |
Junichi Sato
CHM | Chairman | 65 | 28/02/81 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takayuki Oshima
BRD | Director/Board Member | 69 | 24/06/21 |
Junichi Sato
CHM | Chairman | 65 | 28/02/81 |
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 30/11/09 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 2,202 | +4.11% | 12 800 |
26/04/24 | 2,115 | -1.12% | 4,100 |
25/04/24 | 2,139 | -4.25% | 4,900 |
24/04/24 | 2,234 | +3.52% | 19,400 |
23/04/24 | 2,158 | +1.03% | 3,100 |
Delayed Quote Japan Exchange, April 30, 2024 at 07:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 128M | |
+2.88% | 6.34B | |
-2.68% | 1.02B | |
-1.35% | 367M | |
+0.82% | 211M | |
-27.22% | 159M | |
+16.54% | 110M | |
-11.18% | 66.53M | |
-28.10% | 50.41M |
- Stock Market
- Equities
- 7686 Stock